Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Application of Direct Viral Cytopathic Hypothesis to Design Drug Trials in the Battle Against Covid-19 Publisher Pubmed



Ashraf MA1 ; Sherafat A2 ; Pourdast A3, 4 ; Nazemi P4 ; Mohraz M3
Authors

Source: DARU# Journal of Pharmaceutical Sciences Published:2020


Abstract

COVID-19 has caused many deaths worldwide. Systemic complications alongside coagulopathy, and ARDS account for the majority of COVID-19 mortalities. The pathogenesis of the disease can be explained by two theories of direct viral cytopathy and systemic inflammatory cascade of events. ACE-2 is shown to be the cellular host receptor for SARS-CoV-2. It might be the key to explain the pathogenesis of systemic complications with a focus on the direct viral cytopathic hypothesis. Different medications tend to show up in many in vitro drug screens. However, more trials are needed to translate their application into in vivo efficacy. © 2020, Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
2. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
3. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Shadi Sadat Seyyedebrahimi (1)
Other Related Docs
4. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
5. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
6. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)
7. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
8. Coagulopathy and Thromboembolic Events a Pathogenic Mechanism of Covid-19 Associated With Mortality: An Updated Review, Journal of Clinical Laboratory Analysis (2023)
9. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
10. Renal, Cardiac, Neurological, Cutaneous and Coagulopathic Long-Term Manifestations of Covid-19 After Recovery; a Review, Epidemiology and Infection (2022)
11. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
12. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
13. The Coronavirus Disease 2019 and Effect on Liver Function: A Hidden and Vital Interaction Beyond the Respiratory System, Reviews and Research in Medical Microbiology (2022)
14. Pathologic Features of Covid-19: A Concise Review, Pathology Research and Practice (2020)
15. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)
16. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
17. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
18. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
19. Biochemical Parameters and Pathogenesis of Sars-Cov-2 Infection in Vital Organs: Covid-19 Outbreak in Iran, New Microbes and New Infections (2020)
20. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)